Baha' Sharaf

19PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 15, 2026
On-Treatment NLR Dynamics During CDK4/6 Inhibition Are Associated with Overall Survival in Metastatic Breast Cancer.

|Jul 27, 2026
Evolving First-Line Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer: CDK4/6 Inhibition, Biomarker-Guided Strategies and Emerging Therapeutic Paradigms.

|Apr 15, 2026
Bridging Clinical Trials to Real-World Clinical Practice: TCHP Neoadjuvant Therapy Outcomes in HER2-Positive Breast Cancer.

Baha Sharaf, Alaa Seif, Hira Bani Hani

|Oct 03, 2025
Metastasis-Directed Stereotactic Body Radiation Therapy in Oligometastatic and Oligoprogressive Solid Malignancy: Outcomes and Effect on Systemic Treatment.

Abdulla Alzibdeh, Lina Wahbeh, Shatha Abu Taha

|Sep 05, 2025
Enhancing Early Detection of Pancreatic Cancer in Genetically Predisposed Individuals: Integrating Advanced Imaging Modalities with Emerging Biomarkers and Liquid Biopsy.

Rashid Abdel-Razeq, Asem Mansour, Maha Barbar

|Mar 18, 2025
Escalation and De-Escalation Strategies for Endocrine Therapy in Early-Stage Breast Cancer.

Tamer Al-Batsh, Nayef Abdel-Razeq, Yosra Al-Masri

Pageof 4

Frequent Collaborators

17 joint publications

Hikmat Abdel-Razeq

9 joint publications

Faris Tamimi

3 joint publications

Ramiz Abu-Hijlih

3 joint publications

Hira Bani Hani